title: Systemic reactions after intravesical BCG instillation for bladder cancer.
authors.forename: E
authors.initials: E
authors.lastname: Andrès
authors.forename: A
authors.initials: A
authors.lastname: Gaunard
authors.forename: J F
authors.initials: JF
authors.lastname: Blicklé
authors.forename: C
authors.initials: C
authors.lastname: Kuhnert
authors.forename: B
authors.initials: B
authors.lastname: Goichot
authors.forename: J L
authors.initials: JL
authors.lastname: Schlienger
authors.forename: J M
authors.initials: JM
authors.lastname: Brogard
mesh_terms: D000283:Administration, Intravesical; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000890:Anti-Infective Agents; D001500:BCG Vaccine; D015242:Ofloxacin